High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP

Jae-Hoon Song1, Sook-In Jung, Kwan Soo Ko

  • 1Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Asian-Pacific Research Foundation for Infectious Diseases, 50 Il-won dong, Kangnam-ku, Seoul 135-710, Korea. jhsong@smc.samsung.co.kr

Insights

Antimicrobial resistance in Streptococcus pneumoniae is alarmingly high across Asia. Penicillin resistance exceeded 50% in many countries, with specific clones contributing to this rise.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Streptococcus pneumoniae causes severe pneumococcal diseases globally.
  • Antimicrobial resistance (AMR) poses a significant threat to effective treatment.
  • Surveillance of AMR in Asia is crucial due to high population density and varying healthcare access.

Purpose of the Study:

  • To assess the in vitro antimicrobial susceptibility of clinical Streptococcus pneumoniae isolates across multiple Asian countries.
  • To identify trends and prevalence of resistance to key antimicrobial agents.
  • To investigate potential drivers of increasing antimicrobial resistance.

Main Methods:

  • Collection of 685 clinical S. pneumoniae isolates from 14 centers in 11 Asian countries (2000-2001).
  • Determination of in vitro susceptibilities to 14 antimicrobial agents using broth microdilution.
  • Antimicrobial resistance (AMR) profiling and Minimum Inhibitory Concentration (MIC) determination.
  • Multilocus sequence typing (MLST) to identify prevalent clones.

Main Results:

  • Over 52% of isolates were not susceptible to penicillin; 29.4% were resistant (MICs ≥ 2 mg/liter).
  • High rates of erythromycin resistance were observed, particularly in Vietnam (92.1%) and Taiwan (86%).
  • Specific clones, Taiwan(19F) and Spain(23F), were identified as potential drivers of increasing AMR.

Conclusions:

  • Significant increases in antimicrobial resistance prevalence and levels were documented among S. pneumoniae isolates in many Asian countries.
  • Resistance rates in this study are among the highest reported globally.
  • Urgent public health strategies are needed to combat the escalating antimicrobial resistance crisis in the region.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...